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Available online 30 September 2014Abstract Embryonic stem (ES) cells are characterized by pluripotency, defined as the developmental potential to generate cell
lineages derived from all three primary germ layers. In the past decade, great progress has been made on the cell culture
conditions, transcription factor programs and intracellular signaling pathways that control bothmurine and human ES cell fates. ES
cells of mouse vs. human origin have distinct culture conditions, responding to some tyrosine kinase signaling pathways in opposite
ways. Previous work has implicated the Src family of non-receptor protein–tyrosine kinases in mouse ES cell self-renewal and
differentiation. Seven members of the Src kinase family are expressed in mouse ES cells, and individual family members appear to
play distinct roles in regulating their developmental fate. Both Hck and c-Yes are important in self-renewal, while c-Src activity
alone is sufficient to induce differentiation. While these findings implicate Src-family kinase signaling in mouse ES cell renewal and
differentiation, the role of this kinase family in human ES cells is largely unknown. Here, we explored Src-family kinase expression
patterns and signaling in human ES cells during self-renewal and differentiation. Of the eleven Src-related kinases in the human
genome, Fyn, c-Yes, c-Src, Lyn, Lck and Hck were expressed in H1, H7 and H9 hES cells, while Fgr, Blk, Srm, Brk, and Frk transcripts
were not detected. Of these, c-Yes, Lyn, and Hck transcript levels remained constant in self-renewing human ES cells vs.
differentiated EBs, while c-Src and Fyn showed a modest increase in expression as a function of differentiation. In contrast, Lck
expression levels dropped dramatically as a function of EB differentiation. To assess the role of overall Src-family kinase activity in
human ES cell differentiation, cultures were treated with inhibitors specific for the Src kinase family. Remarkably, human ES cells
maintained in the presence of the potent Src-family kinase inhibitor A-419259 retained the morphology of domed, pluripotent
colonies and continued to express the self-renewal marker TRA-1-60 despite culture under differentiation conditions. Taken
together, these observations support a role for Src-family kinase signaling in the regulation of human ES cell fate, and suggest that
the activities of individual Src-family members are required for the initiation of the differentiation program.
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380 X. Zhang et al.Introduction Src-family members c-Src, c-Yes, Fyn, Lck and Lyn underHuman ES (hES) cells are pluripotent stem cells derived from
the inner cell mass of blastocyst stage human embryos
produced by in vitro fertilization (Thomson et al., 1998).
Like mouse ES (mES) cells, hES cells are pluripotent and can
form embryoid bodies in vitro and teratomas in vivo upon
injection into immunodeficient mice. Although hES cells are
of the same blastocyst origin as mES cells, they depend on
distinct receptor tyrosine kinase signaling pathways for
maintenance in culture. For example, hES cells require
bFGF and TGFβ/Activin signals tomaintain the undifferentiated
state. In contrast, factors essential for mES cell self-renewal,
such as LIF and BMPs, either have no effect on hES cells or
induce their differentiation, respectively (Yu and Thomson,
2008). In hES cells, bFGF signals through the FGF receptor
tyrosine kinase to activate Erk signaling which inhibits dif-
ferentiation and the PI3K-Akt pathway to promote survival
(Dvorak et al., 2005; Li et al., 2007). In addition, the TGFβ/
Nodal/Activin signaling axis inhibits neuronal differentiation,
and works synergistically with bFGF to maintain hES cell
pluripotency (Vallier et al., 2005). Despite these differences
in growth factor requirements between mES and hES cells, the
core transcription factors governing pluripotency are similar,
with both mES and hES cells expressing themaster pluripotency
factors, Oct4, Nanog and Sox2 (Boyer et al., 2005). While
the growth factor conditions, receptor kinase signaling, and
transcription factor networks governing hES cell fate have
been examined in detail, the intracellular signaling pathways
downstream of receptor tyrosine kinases have not been
fully explored.
The Src family of non-receptor tyrosine kinases is coupled
to many growth factor receptors (including the FGFR) to
regulate cell adhesion, proliferation, growth and survival
(Parsons and Parsons, 2004; Boggon and Eck, 2004). There
are eleven Src-related kinases in the human genome (Manning
et al., 2002), eight of which have been studied extensively in
mammalian cells (Blk, Fgr, Fyn, Lck, Lyn, Hck, c-Src and c-Yes)
plus three phylogenetically related kinases (Srm, Frk and Brk).
In adult mice, c-Src, Fyn and c-Yes are ubiquitously expressed,
while Lck, Lyn, Hck, Blk and Fgr are more restricted in
their expression patterns, primarily to hematopoietic cells
(Lowell and Soriano, 1996). Surprisingly, at least seven
members of the Src kinase family are expressed in mES cells,
and individual family members appear to play distinct roles
in regulating their developmental fate (Meyn et al., 2005).
For example, the expression of Hck is rapidly silenced as
mES cells differentiate to embryoid bodies (EBs), suggesting
a role in self-renewal or the suppression of differentiation.
In contrast, c-Src is expressed and active in both pluripotent
mES cells and EBs derived from them, and its activity
alone is sufficient to induce differentiation of mES cells to
primitive ectoderm and endoderm (Meyn et al., 2005; Meyn
and Smithgall, 2009). Other studies have shown that both
Hck and c-Yes are important for mES cell self-renewal
downstream of LIF (Ernst et al., 1994; Anneren et al., 2004;
Tamm et al., 2011), and that c-Yes may have a similar role in
human ES cells (Anneren et al., 2004).
In this study, we performed a comprehensive analysis of
Src-family kinase (SFK) expression and signaling during hES
cell self-renewal and differentiation. The hES cell lines H1,
H7 and H9 all express comparable mRNA levels of theculture conditions for self-renewal. Remarkably, Lck ex-
pression decreased dramatically as hES cells differentiated;
Lck transcript and protein levels were lost more rapidly than
those of the well-known pluripotency marker Oct4 during
EB formation. The observed changes in Lck expression and
activity are unique to hES cells as compared to mES cells,
and suggest a possible role in the maintenance of the
undifferentiated state. In contrast, c-Src, c-Yes and Fyn
message levels did not change during differentiation,
similar to previous observations in mES cells. We also
found differences in SFK activity as a function of hES cell
differentiation. c-Src, Fyn and Lyn were active in renewing hES
cells and differentiated EBs, while Lck and c-Yes were active
only in self-renewing hES cells. To investigate the requirement
for SFK activity in differentiation, hES cell cultureswere treated
with smallmolecule SFK inhibitors previously tested inmES cells
(Meyn and Smithgall, 2009; Meyn et al., 2005). Remarkably, hES
cells treated with the potent pan-SFK inhibitor A-419259
retained colony morphology and marker expression character-
istic of pluripotency even under culture conditions for
differentiation. Immunoblots confirmed that this compound
blocked all endogenous SFK activity, including that of Lck
and c-Src. These observations demonstrate that the activ-
ities of several Src-family members are required for hES cells
to initiate the differentiation program, and that SFK signals for
differentiation may be dominant to those for self-renewal.
Materials and methods
Cell culture
Human ES cell lines H1, H7, and H9 (WiCell WA01, WA07 and
WA09) were maintained in feeder-free culture conditions
with mTeSR medium (Stemcell Technologies) on 6-well
plates coated with hESC-qualified Matrigel (BD Biosciences)
as described (Schatten et al., 2005). The culture medium
was changed daily, and cells were passaged every 5–7 days
thereafter using Dispase (Stemcell Technologies) as per the
manufacturer's instructions.
EB formation
ES cells were dissociated into single cells with Accutase
(Stemcell Technologies), pelleted and re-suspended in mTeSR
medium containing the Rho kinase inhibitor, Y27632 (10 μM).
Viable cells were counted using Trypan Blue (Invitrogen)
and 2000 cells were loaded into each microwell of AggreWell
plates (Stemcell Technologies). EBs were harvested 24 h later,
re-suspended in AggreWell medium (Stemcell Technologies) or
differentiation medium (described below) and maintained on
ultra-low attachment plates (Corning). EBs were harvested 3,
9 and 12 days after initiation and were washed using a cell
strainer (BD Biosciences) to remove single cells before lysis.
Inhibitor treatment
ES cells were passaged onto Matrigel-coated 6-well plates
and maintained in mTeSR medium for three days. Culture
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tion medium with or without SFK inhibitors for an additional
three days. Differentiation medium was composed of 5%
knockout serum replacement, 15% fetal bovine serum, 1%
non-essential amino acid, 1% L-glutamine, and 1% Pen/Strep in
DMEM/F-12 medium (all components from Life Technologies).
The SFK inhibitors SKI-1 and PP2 were purchased from EMD-
Millipore-Calbiochem while A-419259 was purchased from
Santa Cruz Biotechnology.
RT-PCR
RNA isolation, RT-PCR, quantitative real-time RT-PCR, and
data analysis were performed as described in detail elsewhere
(Zhang et al., 2014).
Immunoprecipitation and immunoblots
Cells were washed with phosphate-buffered saline (PBS) and
lysed with RIPA buffer supplemented with phosphatase and
protease inhibitors as described (Meyn et al., 2005). SFK
proteins were immunoprecipitated from equivalent amounts
of clarified ES cell lysates with isoform-specific antibodies
and protein G-Sepharose as described elsewhere (Zhang
et al., 2014; Meyn and Smithgall, 2009; Meyn et al., 2005).
Immunoprecipitated proteins as well as cell lysates were
separated by SDS-PAGE, transferred to PVDF membranes and
probed with antibodies to the SFK activation loop, each SFK
protein, Oct4, and actin as a loading control. Antibodies
used for these studies are summarized in Table S1.
Immunofluorescence microscopy
Cells were plated onto Matrigel-coated coverslips in 6-well
plates and maintained in mTeSR medium for three days. The
cell culture medium was then switched to differentiation
medium or fresh mTeSR with or without inhibitors for three
additional days. Cells were then washed with PBS, fixed in
4% paraformaldehyde (Sigma) for 15 min, and blocked with
PBS containing 5% bovine serum albumin (Fisher) and 5%
normal goat serum (Invitrogen) for 1 h at room temperature.
Cells were then incubated with primary antibodies overnight
at 4 °C in blocking buffer, followed by 3 washes with PBS.
Cells were then incubatedwith secondary antibodies coupled to
various fluorescent probes at 37 °C for 1 h followed by 3
additional washes. Cells were then sealed with coverslips using
mounting medium containing DAPI to stain the nuclei (Vector
Laboratories). Antibodies used for immunocytochemistry
fluorescence are summarized in Table S1.
Results
Human ES cells express multiple Src-family kinases
Despite the expression of eleven Src-related kinases in the
human genome, only c-Yes has been studied in the context
of hES cell biology (Anneren, 2008). While the c-Yes protein
is expressed in both pluripotent hES cells and differentiated
EBs derived from them, c-Yes kinase activity is downregu-
lated as hES cells differentiate to EBs (Anneren et al., 2004;Zhang et al., 2014). This observation provided the first
evidence that c-Yes, and possibly other members of the Src
kinase family, may regulate hES cell fate. To study SFK
signaling in hES cells more broadly, we first determined
which family members are expressed in hES cells using
RT-PCR. For this study, we cultured the hES cell lines H1, H7
and H9 in chemically defined mTeSR self-renewal medium
under-feeder free conditions on Matrigel-coated plates
(Ludwig et al., 2006). All three cell lines grew as domed
colonies, with some evidence of differentiation at the edge
of each colony (Fig. 1A). RT-PCR analysis revealed that H1
hES cells express six SFKs, including c-Src, c-Yes, Fyn, Lck,
Hck and Lyn. Of these, c-Src, c-Yes, Fyn and Lck are the most
strongly expressed (Fig. 1B). The pluripotency marker Oct4
was included in this experiment as a positive control.
We next determined the relative expression levels of
these six SFKs in comparison to the pluripotency markers
Oct4 and Nanog across all three hES cell lines using
quantitative real-time RT-PCR (qPCR, Fig. 1C). The H7 and
H9 cell lines were observed to express the pluripotency
marker Oct4 as well as the SFKs Fyn, c-Src, c-Yes, Lck and
Lyn at levels comparable to H1 cells by this approach, with
less than two-fold variation across the three hES cell lines.
In contrast, the expression of the pluripotency marker Nanog
and the SFK Hck was more variable, indicative of some
heterogeneity between these hES cell lines. Nevertheless,
these results show that hES cells express multiple Src-family
members, with the expression levels of c-Src, c-Yes, Fyn and
Lck most consistent among the three hES cell lines tested.Src family kinase expression during hES
cell differentiation
Embryoid body (EB) formation is a convenientmodel for ES cell
differentiation in vitro. When cultured in suspension without
feeder layers, hES cells spontaneously form aggregates known
as EBs similar to those described for mES cells (Itskovitz-Eldor
et al., 2000). Developing EBs express differentiation markers
characteristic of all three germ layers, and mimic the early
developmental stages of gastrulation and preimplantation
embryogenesis (Murry and Keller, 2008).
Previous work has shown that individual Src family
members exhibit dynamic expression changes as mES cells
differentiate to EBs (Meyn et al., 2005). To investigate
whether SFKs are also differentially regulated during hES cell
differentiation, EB formation was initiated from H7 hES cells
using AggreWell microplates starting with an equal number of
cells per well (Mohr et al., 2010). EBs were harvested 3, 6 and
12 days later (see Fig. 2A for morphology), and total RNA was
extracted for qPCR analysis of gene expression. As controls
for the differentiation process, we first assessed the expres-
sion of pluripotency and germ layer markers (Fig. 2B). The
self-renewal markers Oct4 and Nanog were down-regulated in
EBs, while the differentiation markers T (mesoderm), Pax6,
Sox1 and Msx1 (ectoderm) increased significantly, consistent
with EB differentiation. Expression of Lck and Hck was
rapidly downregulated in response to EB formation, suggesting
that these SFKs may be important for hES cell renewal
(Fig. 2B). Lyn expression was also downregulated in day 12
EBs compared with control ES cells, but to a lesser extent than
Hck and Lck. In contrast, expression of c-Src, c-Yes and Fyn
Figure 1 Profile of SFK gene expression in hES cells. A) The hES cell lines H1, H7 and H9 were maintained under feeder-free
conditions on Matrigel-coated plates using mTeSR1 medium. All three lines grew as large domed colonies with well-circumscribed
boundaries. B) H1 hES cells were harvested 5 days after passage for RNA isolation. SFK (Blk, Fgr, Fyn, Hck, Lck, Lyn, c-Src, c-Yes),
Src-related kinase (Brk, Frk, Srm) and pluripotency marker (Oct4) expression were determined by RT-PCR with GAPDH as a positive
control. Images of agarose gels of the PCR products are shown after 30 and 35 PCR cycles. C) Relative SFK (Fyn, Hck, Lck, Lyn, c-Src,
c-Yes) and pluripotency marker (Oct4, Nanog) expression levels across three hES cell lines. Transcript levels for the indicated genes
were determined by quantitative real-time RT-PCR for the H1, H7 and H9 hES cell lines. The results are expressed as the average
fold-change in mRNA level in H7 and H9 cells relative to H1 cells ± SEM (n = 3, *p b 0.05; pairwise fixed reallocation randomization
test). SFK expression varied by less than 2-fold across these hES cell lines (gray area), with the exception of Hck expression in H7 cells.
382 X. Zhang et al.was maintained throughout EB formation, indicating that these
three kinases may have roles to play in both self-renewing hES
cells and differentiated EBs. Similar results were observed
during EB formation from H1 hES cells (data not shown).
We next explored SFK protein expression patterns and
activity levels in immunoprecipitates from the hES cell lines
H1 and H7 as well as 6-day EBs derived from them. We also
included themES cell line D3 in this study for comparison. Three
Src-family members showed similar expression and activity
profiles in human and mouse ES cells and EBs (Fig. 3). c-Src and
Fyn were strongly expressed and active in both self-renewing
and differentiated hES cells. The same is true for mES cells,
consistent with our previous results (Meyn and Smithgall, 2009;
Meyn et al., 2005). While the c-Yes protein is present in
self-renewingmouse and human ES cells as well as EBs, it is only
active in self-renewing stem cells, which is also consistent with
an earlier report (Anneren et al., 2004). Interestingly, three
other SFKs showed differences in protein expression and activity
between mouse and human ES cells. Hck was present and
active in self-renewing mES cells, but was not detected
in differentiated day 6 mouse EBs as observed previously(Meyn et al., 2005). Unlike mES cells, however, we could not
detect Hck protein in self-renewing human ES cells or EBs,
despite the presence of Hck transcripts by RT-PCR. In contrast
to Hck, Lck was highly expressed and active in both lines of
self-renewing hES cells but not inmES cells. Similar to c-Yes, Lck
activity was completely repressed in differentiated EBs derived
from both hES cell lines. Lck protein levels were also decreased
as a function of differentiation, consistent with the decreased
transcript levels observed by qPCR. However, Lck protein was
still detectable in 6-day EBs, even though its activity appears to
be downregulated based on loss of activation loop phosphory-
lation on Tyr418. These observations suggest that regulation of
Lck signaling in hES cells may be complex, involving both gene
transcription and regulation of kinase function.Inhibition of Src-family kinase activity blocks hES
cell differentiation
The dynamic changes in SFK expression patterns (Lck) and
activity (Lck and c-Yes) that occur during EB formation
Figure 2 SFK expression during EB formation from H7 hES cells. A) EB formation was initiated from H7 hES cells using AggreWell plates
as described under the Materials and methods section. Representative images of H7 hES cells and EBs after 3, 6 and 12 days of culture are
shown; all images recorded at same magnification (100×). B) Total RNA was extracted from renewing hES cells and 3, 6, and 12-day EBs.
Expression of self-renewal (Oct4, Nanog) and differentiation markers (T, mesoderm; Pax6, Sox1, Msx1, ectoderm; and Sox17, endoderm)
as well as SFKs (Fyn, Hck, Lck, Lyn, c-Src, c-Yes) was determined by qPCR relative to control H7 hES cells maintained in mTeSR medium.
Results are expressed as the average fold change relative to the undifferentiated hES cell population ± S.E.M. (n = 3; *p b 0.05; pairwise
fixed reallocation randomization test).
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family might influence hES cell growth and differentiation.
To test this idea, we employed the pyrrolopyrimidine
compound A-419259, which is a potent, cell-active in-
hibitor selective for the Src-kinase family (Meyn and
Smithgall, 2009). Previous studies showed that the inhi-
bition of endogenous SFK activity with this compound
maintained mES cell pluripotency in the absence of LIF
while reversibly inhibiting EB formation (Meyn et al.,
2005). Subsequent work attributed the effects of A-419259
treatment to the inhibition of c-Src, which drives differ-
entiation of mES cells towards primitive ectoderm-like
cells (Meyn and Smithgall, 2009). Using A-419259 concen-
trations determined in previous studies with mES cells, we
tested whether this SFK inhibitor produced similar effects on
hES cells.For inhibitor experiments, the H1 and H7 lines of hES cells
were passaged onto Matrigel-coated plates and grown in
self-renewal medium (mTeSR) for three days. The culture
mediumwas then replacedwith either differentiationmedium
or fresh renewal medium in the presence or absence of
A-419259 for an additional three days, followed by the
assessment of colony morphology and pluripotency marker
expression. As shown in Fig. 4, A-419259 treatment had no
effect on the undifferentiated colony morphology of hES
cells grown in mTeSR medium. However, when hES cells
were switched to differentiation medium in the presence
of 1 μM A-419259, they retained the domed morphology
characteristic of pluripotent colonies. This effect was not
observed when the inhibitor concentration was lowered
to 0.3 μM, suggesting a threshold effect similar to that
observed previously in mES cells (Meyn et al., 2005).
Figure 3 SFK protein expression and activity in ES cells and
6 day EBs. Lysates were prepared from mouse ES cells (D3 line),
human ES cells (H1 and H7 lines) and 6-day EBs derived
from them. Endogenous SFKs (c-Src, c-Yes, Fyn, Lck, Hck, Lyn)
were immunoprecipitated and blotted with a phosphospecific
antibody for the active form of each kinase (pY418 antibody,
which recognizes the conserved phosphotyrosine residue in the
activation loop of the kinase domain) as well as the respective
SFK protein. Cell lysates were also blotted for Oct4 as marker
of ES cell self-renewal plus actin as a loading control. This
experiment was repeated twice with comparable results;
a representative example is shown.
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A-419259 treatment on hES cell colony morphology corre-
lated with inhibition of endogenous SFK activity. For this
experiment, self-renewing H1 hES cells were treated over-
night with A-419259 followed by the immunoblotting of cell
lysates with a phosphospecific antibody to detect active
SFKs. As shown in Fig. 5, constitutive SFK activity was readily
detected in untreated hES cells that were almost completely
blocked in the presence of A-419259. We also examined
the effect of A-419259 treatment on Lck and c-Src kinaseactivities individually. For this experiment, Lck and c-Src were
immunoprecipitated from control and inhibitor-treated cells,
followed by immunoblotting with the phosphospecific anti-
body. Lck and c-Src activities were completely inhibited
in immunoprecipitates from A-419259-treated cells. These
findings are consistent with our previous observations with
this inhibitor in mES cells (Meyn and Smithgall, 2009; Meyn
et al., 2005), and support a role for c-Src in the initiation of
hES differentiation.
Human ES cells maintain cell-surface renewal marker
expression following SFK inhibition under
differentiation culture conditions
To determine whether SFK inhibition affects pluripotency
marker expression in hES cells, we first determined the
effect of A-419259 treatment on the cell-surface expression
of Tra-1-60, one of the most stringent markers for hES cell
pluripotency (Chan et al., 2009). H1 hES cells were cultured
on mTeSR renewal medium or under differentiation condi-
tions in the presence or absence of A-419259 for three days
as described above. Cells were then fixed and stained for
Tra-1-60 as well as DAPI (Fig. 6). Untreated hESC cultures
stained strongly with Tra-1-60 under self-renewal conditions
while the switch to differentiation medium resulted in a
dramatic loss of Tra-1-60 expression. However, hES cells
grown in the presence of A-419259 continued to express
TRA-1-60 despite the switch to differentiation culture
conditions (Fig. 6), consistent with the maintenance of
rounded undifferentiated colonies observed in the presence of
this inhibitor (Fig. 4). Treatment of the H7 line of hES
cells with A-419259 also resulted in sustained expression of
cell-surface Tra-1-60 despite the switch to differentiation
medium (data not shown).
Loss of Lck expression is an early indicator of hES
cell differentiation
In a final series of experiments, we investigated changes in
Lck protein expression at the single cell level as a function of
differentiation. For these studies, H7 hES cells were cultured
under renewal and differentiation conditions for three days
in the presence or absence of A-419259. The cells were then
fixed, permeabilized and immunostained for Lck protein
expression, as well as Oct4 as a marker of pluripotency. As
shown in Fig. 7, Lck expression was readily detected in
self-renewing ES cells, with clear subcellular localization to
the cell periphery. Nuclear Oct4 staining was also observed,
and neither Oct4 nor Lck expression was affected by
A-419259 treatment under self-renewal culture conditions.
On the other hand, hES cells grown for three days under
differentiation conditions showed a dramatic reduction in
Lck immunofluorescence, even though Oct4 expression was
still evident. Remarkably, hES cells cultured in differentiation
medium containing A-419259 retained very strong expression
of Lck, with expression now observed throughout the cells
and not just limited to the cell periphery. These results are
consistent with the reduction in Lck expression and activity
observed during EB formation from hES cells described earlier
(Figs. 2 and 3) and identify the Src-family member Lck as a
very sensitive indicator of hES cell pluripotency. As a control,
Figure 4 hES cells treated with the small molecule SFK inhibitor A-419259 retain undifferentiated colony morphology. The H1 and
H7 hES cell lines were grown in mTeSR self-renewal medium or switched to differentiation medium in the absence or presence of
the pan-SFK inhibitor, A-419259, at the concentrations shown. Note that both hES cells lines maintained undifferentiated colony
morphology when cultured in the presence of A-419259 under differentiation conditions.
385Src-family tyrosine kinase activities essential for differentiation of human embryonic stem cellswe also looked at the expression and subcellular localization
of c-Src by immunofluorescence under the same four culture
conditions. Unlike Lck, neither the staining intensity nor the
subcellular localization of c-Src to the cell periphery changed
as a function of differentiation (data not shown).
A final point relates to morphological changes shown
in Fig. 7 in relation to overall colony morphology presented
in Fig. 4 under similar culture conditions. Changes to H7
hESC colony morphology or “compactness” as a function of
differentiation or inhibitor treatment can be inferred from
the size of and distance between the nuclei in Fig. 7.
Individual nuclei are clearly visible in the images stained
with both DAPI and Oct4. Under conditions of self-renewal,
the nuclei appear smallest and most closely packed together,
consistent with tight colony morphology associated withself-renewal as shown in Fig. 4. Under self-renewal conditions,
A-419259 treatment had no discernable effect on colony
morphology. In contrast, nuclei from cells grown under
differentiation conditions (without A-419259) appear larg-
er and further apart (Fig. 7), consistent with the loss
of compact colony morphology and cell spreading that
accompanies differentiation. On the other hand, nuclei in
Fig. 7 from cultures treated with A-419259 under differ-
entiation conditions appear smaller, closer together and
more closely resemble the size and packing of those in
undifferentiated colonies. Careful inspection of colony
morphology in Fig. 4 also shows that self-renewing colonies
are more clearly circumscribed and tightly packed than
those from cells grown under differentiation conditions
with A-419259.
Figure 5 A-419259 inhibits endogenous SFK activity in hES
cells. Self-renewing hES cells (H1 and H7 lines) were cultured in
the absence or presence of A-419259 (1.0 μM) for 16 h, followed
by lysis and immunoprecipitation of c-Src and Lck. Each
immunoprecipitate was then blotted with a phosphospecific
antibody for the active form of each kinase (pY418 antibody,
which recognizes the conserved phosphotyrosine residue in the
activation loop of the kinase domain) as well as the respective
SFK protein. Cell lysates were also blotted for pY418 as well as
Oct4 as a marker of ES cell self-renewal. This experiment was
repeated twice with comparable results; a representative
example is shown.
Figure 6 hES cells retain Tra-1-60 expression following SFK inhib
medium or switched to differentiation medium in the absence (DMSO
concentrations shown. Cells were fixed and immunostained for t
(magnification 400×). This experiment was repeated three times w
condition are shown.
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In this study, we found that hES cells express multiple Src-
family members, with c-Src, c-Yes, Fyn, Lck and Lyn readily
detected at both the transcript and protein levels. Using a
phosphospecific antibody for the active form of each kinase,
we also observed that all five kinases appear to be
constitutively active in self-renewing ES cells. Differentia-
tion of hES cells to EBs was associated with the loss of Lck
and c-Yes kinase activities, as well as potent silencing of Lck
gene expression. In contrast, c-Src and Fyn gene expres-
sions, protein levels and kinase activity were maintained
throughout differentiation. These results suggest that Lck
and c-Yes activities may influence self-renewal, while c-Src
and Fyn signaling may be related to differentiation. Previous
results have shown that c-Yes is expressed and active in both
mouse and human ES cells under self-renewal conditions
(Anneren et al., 2004), and that enforced expression of c-Yes
interferes with EB formation from mES cells (Zhang et al.,
2014). On the other hand, both c-Src and Fyn are present and
active in self-renewing mES cells as well as EBs formed from
them. Other studies have shown that c-Src activity alone is
sufficient to drive mES cells towards primitive ectoderm and
endoderm, and also induces the expression of several genes
that regulate the epithelial to mesenchymal transition
associated with early embryogenesis (Zhang et al., 2014;
Meyn and Smithgall, 2009). Our findings that c-Src is also
constitutively expressed and active in EBs derived from hES
cells support a similar role for this family member in the
control of human EB formation. Other work has shown that
c-Src is highly expressed and active following induction of
hES cell differentiation with retinoic acid, consistent withition. The H1 line of hES cells was grown in mTeSR self-renewal
carrier) or presence of the pan-SFK inhibitor, A-419259, at the
he cell-surface pluripotency marker Tra-1-60 three days later
ith comparable results; representative fields of cells from each
Figure 7 Loss of Lck expression accompanies hES cell differentiation. The H7 line of hES cells was grown in mTeSR self-renewal
medium or switched to differentiation medium in the absence (Control) or presence of A-419259 (1 μM). Cells were fixed,
permeabilized and immunostained for the SFK Lck and the nuclear pluripotency factor Oct4 four days later. DAPI-stained nuclei are
also shown. The merged image combines cells in the Lck and Oct4 panels only. This experiment was repeated three times with
comparable results; a representative field of cells is shown for each condition.
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recently demonstrated that the differentiation-promoting
activity of c-Src is antagonized by c-Yes in mES cells, despite
their very close phylogenetic relationship (Zhang et al.,
2014). A similar balance between c-Yes and c-Src signaling
may control the differentiation of hES cell as well.
Our observation that self-renewing hES cells express high
levels of active Lck is surprising given that Lck expression is
largely restricted to T-lymphocytes in adults. Immunofluo-
rescence microscopy demonstrates that Lck localizes to the
cell periphery, suggesting that it may interact with growth
factor or cytokine receptors in the hES cell context.
Previous microarray studies have identified Lck as a highly
expressed gene in pluripotent hES cells vs. their differen-
tiated counterparts (Cao et al., 2008). In addition, a global
phosphoproteomic study of hES cells identified Lck as
a signaling protein with more abundant phosphorylation
site identifications in pluripotent hES cells compared to
differentiated hES cell derivatives (Brill et al., 2009). These
results are consistent with our findings that Lck activity
and gene expression are rapidly downregulated as hEScells differentiate, and further implicate Lck in signaling
events related to hES cell self-renewal or suppression of
differentiation.
Other studies have implicated another hematopoietic
SFK, Hck, in mES cell self-renewal. Hck activity is stimulated
by the self-renewal cytokine LIF in mES cells (Ernst et al.,
1994), and Hck gene expression is rapidly silenced as mES
cells differentiate to EBs (Meyn et al., 2005). In contrast
to mES cells, however, we detected only low levels of Hck
transcripts in self-renewing hES cells and were unable
to detect Hck protein or activity in hESCs or EBs. This
remarkable difference in Hck expression may reflect an
important difference in the pluripotent state exemplified by
human vs. mouse ES cells- ]–> — the naïve and primed states
(Nichols and Smith, 2009). Whereas mES cells represent the
naïve pluripotent state, hES cells typify primed pluripotency
and are more like mouse epiblast stem (EpiS) cells.
Interestingly, while Hck is highly expressed in mES cells,
we found that it is down-regulated in mouse EpiS cells
(data not shown). Thus, Hck may represent a specific marker
of naïve pluripotency, which explains why it is strongly
388 X. Zhang et al.expressed in mES cells yet only expressed in hES cells at very
low levels.
Using the potent Src-family kinase inhibitor, A-419259,
we also explored the role of SFK activity in hES cell fate.
Treatment of hES cells with this inhibitor blocked all
endogenous Src-family kinase activity, including that of
c-Src and Lck. As a consequence, hES cells treated with the
inhibitor grew as domed, morphologically undifferentiated
colonies even when cultured in differentiation medium.
Similar results were obtained with two additional Src-
family kinase inhibitors from other chemical classes: the
pyrazolopyrimidine, PP2, and the anilino-quinazoline, SKI-1
(data not shown) (Meyn et al., 2005). Furthermore, hES cells
continued to express the well-established cell-surface marker
for self-renewal, Tra-1-60, when cultured with A-419259
under differentiation conditions. Finally, addition of A-419259
to AggreWell cultures of hES cells completely blocked the
formation of EBs (data not shown), a result similar to that
observed previously with mES cells (Meyn et al., 2005). Taken
together, these observations strongly suggest that SFK activity
is required for hES cell differentiation to occur.
A-419259 inhibits all members of the Src-kinase family
to a similar extent, including kinases linked to opposing
functions in ES cell self-renewal (e.g., Lck or c-Yes) vs.
differentiation (c-Src). However, the net effect of global
SFK inhibition is suppression of hES cell differentiation,
a phenotype very similar to that reported previously in mES
cells (Zhang et al., 2014; Meyn and Smithgall, 2009; Meyn
et al., 2005). This observation supports the idea that a
hierarchy of SFK signaling exists in ES cells, in which kinases that
influence self-renewal are dominant over those that initiate
differentiation. When both classes of kinases are blocked, then
the ES cells become trapped in the undifferentiated state.
A complete understanding of the complex and opposing
roles of individual Src-family members in hES cell differenti-
ation will require future studies of individual kinase functions.
One approach is to use RNA interference to selectively
block the expression of individual kinases. For example, RNAi
knockdown of c-Yes caused ES cells to lose self-renewal
marker expression and undergo differentiation (Anneren et
al., 2004). However, knockdown approaches may suffer from
the same limitations as knockout mice, in that functional
compensation through upregulation of redundant kinases may
occur during the selection process required to establish the
knockdown cell population. In addition, knockdown and
knockout approaches, in contrast to pharmacological inhibi-
tion, eliminate the kinase protein entirely thus removing
possible adaptor or other functions that are independent
of protein kinase activity. Another approach is the use of
selective kinase inhibitors. However, because of the highly
conserved nature of Src-family kinase domains, truly selective
ATP-competitive inhibitors for individual SFKs are not
currently available. An alternative is to use a chemical
genetics approach, in which small molecule kinase inhibitors
are combined with genetic mutations to achieve selective
inhibition or resistance for a specific kinase. Previous work
showed that the expression of an inhibitor-resistant mutant of
c-Src rescued mES cells from the A-419259-induced differen-
tiation block, providing important evidence that c-Src activity
is essential for mES cell differentiation (Meyn and Smithgall,
2009). Future studies will explore the development of
isoform-selective inhibitors and activators of individualSrc-family members. Such compounds may represent valuable
chemical probes for the role of individual Src-family kinases
in both mouse and human ES cell differentiation and may
ultimately have translational value in the control of hES
cell fate.
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